Evidence map›Paper›PMID 32474644›Full record

ArticleArchives of microbiology2020

Draft genome sequence of Streptomyces tunisialbus DSM 105760

Ameni Ayed, Daniel Wibberg, Imène Zendah El Euch, Marcel Frese, Ferid Limam, Norbert Sewald

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Rhizobacterium streptomyces sp. NEAU-383 as a potential biocontrol agent to control tomato bacterial wilt.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ameni AyedLaboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria (CBBC), BP-901, 2050, Hammam-Lif, Tunisia.
Daniel WibbergCenter for Biotechnology (CeBiTec), Bielefeld University, 33501, Bielefeld, Germany.
Imène Zendah El EuchOrganic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, 33615, Bielefeld, Germany.
Marcel FreseOrganic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, 33615, Bielefeld, Germany.
Ferid LimamLaboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria (CBBC), BP-901, 2050, Hammam-Lif, Tunisia.
Norbert SewaldOrganic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, 33615, Bielefeld, Germany. norbert.sewald@uni-bielefeld.de.ORCID http://orcid.org/0000-0002-0309-2655

Funding

Bundesministerium für Bildung und Forschung (DE) 031A533Deutscher Akademischer Austauschdienst 57166072
6 · The paper itself

Abstract

Streptomyces strains are well known as promising source of bioactive secondary metabolites, important in ecology, biotechnology and medicine. In this study, we present the draft genome of the new type strain Streptomyces tunisialbus DSM 105760

Indexed as

Base CompositionBase SequenceGenome, BacterialStreptomycesAntiSMASH 5.1.2Draft genomeSecondary metabolitesStreptomyces tunisialbus

Identifiers

PMID32474644
PMCPMC7385001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.